4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-002500
Chief Development Officer gave up 404 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Gamelin Erick · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-14 | Shares withheld for taxes : show line 1 in the form | −404 | $1.92 | $776 | 14,408 | D |
Loading xslF345X06/form4.xml…